Results 1 to 10 of about 717,448 (303)

Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study

The Breast Journal, 2022
Background. Estrogen and progesterone receptor status can predict breast cancer patient prognosis and treatment sensitivity, but research on low ER and PR levels and expression balance remains limited. Methods.
Jin Liu, Mingyu Gan, Zijing Lin, Qin Deng, Juan Deng, Bin Zeng, Yanling Shi, Jia Ming   +7 more
doaj   +1 more source

Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center

Diabetology & Metabolic Syndrome, 2017
Background Diabetes is a progressive disease needing multiple drugs for achieving and maintaining good glycemic control. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) is a novel class of anti-diabetic agent which offers several beneficial effects ...
Yotsapon Thewjitcharoen, Nalin Yenseung, Areeya Malidaeng, Soontaree Nakasatien, Phawinpon Chotwanvirat, Sirinate Krittiyawong, Ekgaluck Wanothayaroj, Thep Himathongkam   +7 more
doaj   +1 more source

Recurrence Factors and Characteristic Trends of Papillary Thyroid Cancer over Three Decades

International Journal of Endocrinology, 2021
Background. The prevalence of thyroid cancer is rising worldwide. Although thyroid cancer has a favorable prognosis, up to 20% of patients experienced recurrent disease during the follow-up period.
Waralee Chatchomchuan, Yotsapon Thewjitcharoen, Krittadhee Karndumri, Sriurai Porramatikul, Sirinate Krittiyawong, Ekgaluck Wanothayaroj, Somboon Vongterapak, Siriwan Butadej, Veekij Veerasomboonsin, Auchai Kanchanapitak, Rajata Rajatanavin, Thep Himathongkam   +11 more
doaj   +1 more source

miR-576-5p Promotes the Proliferation of Papillary Thyroid Carcinoma through the MAPK4-AKT Pathway

International Journal of Analytical Chemistry, 2022
Background. MicroRNA-576-5p (miR-576-5p) plays an important role in different human cancers. However, the biological function of miR-576-5p in papillary thyroid carcinoma (PTC) is still unclear.
Rui Hai, Yang Zhou, Fan Li, Qingxi Guo, Yang Long, Fang Wang, Lian Cheng, Fei Wu, Shi Chen, Xiangyu Zhou   +9 more
doaj   +1 more source

lncRNA MIR503HG Targets miR-191-5p/PLCD1 Axis and Negatively Modulates Apoptosis, Extracellular Matrix Disruption, and Inflammation in Abdominal Aortic Aneurysm

Mediators of Inflammation, 2023
As the most prevalent subtype of aortic aneurysm, abdominal aortic aneurysm (AAA) features the apoptosis, extracellular matrix (ECM) disruption, and inflammation response of vascular smooth muscle cells (VSMCs).
Ye Tian, Xinxi Li, Chao Bai, Zhenwei Yang, Lei Zhang, Jun Luo, Wenbin Zhang   +6 more
doaj   +1 more source

Risk Factor Analysis and Prediction of Severe Hypocalcemia after Total Parathyroidectomy without Auto-Transplantation in Patients with Secondary Hyperparathyroidism

International Journal of Endocrinology, 2023
Objective. Our study aimed to develop and validate a nomogram to predict severe hypocalcemia (SH) before total parathyroidectomy (TPTX) without auto-transplantation in patients with secondary hyperparathyroidism. Methods.
Chenchen He, Yibing Zhang, Longfei Li, Guangming Cheng, Wei Zhang, Yufu Tang, Chunhui Wang   +6 more
doaj   +1 more source

Duration of antithyroid drug treatment may predict weight gain after radioactive iodine therapy in patients with Graves’ disease

Heliyon, 2022
Background: Weight gain post-radioiodine (RAI) treatment is observed in patients with hyperthyroid Graves’ disease. Previous studies, mostly in Caucasian patients, demonstrated excessive weight gain averaging 5–7 kg from initial presentation.
Thewjitcharoen Yotsapon, Chatchomchuan Waralee, Prasatkaew Hussamon, Srichomchey Panita, Butadej Siriwan, Nakasatien Soontaree, Wanothayaroj Ekgaluck, Rajatanavin Rajata, Himathongkam Thep   +8 more
doaj   +1 more source

Impact of first-line treatment choice on long-term outcomes of hyperthyroid Graves’ disease patients with thyrotoxic periodic paralysis

Journal of Clinical & Translational Endocrinology, 2020
Background: Thyrotoxic periodic paralysis (TPP) is a unique manifestation of Graves’ disease. While it is uncommon in Asian, it is extremely rare in Caucasian patients (0.1–0.2%).
Krittadhee Karndumri, Yotsapon Thewjitcharoen, Waralee Chatchomchuan, Sriurai Porramatikul, Sirinate Krittiyawong, Ekgaluck Wanothayaroj, Siriwan Butadej, Soontaree Nakasatien, Rajata Rajatanavin, Thep Himathongkam   +9 more
doaj   +1 more source

Postpartum thyroid function following LT4 treatment from infertility treatment to delivery in women with subclinical hypothyroidism or high-normal TSH: a retrospective study

BMC Endocrine Disorders
Background Levothyroxine (LT4) therapy is commonly initiated in women undergoing infertility treatment who have high-normal thyroid-stimulating hormone (TSH) levels (HN) or subclinical hypothyroidism (SCH).
Yuka Tsukamoto, Yoh Hidaka, Yoshiko Fukuda, Yuko Wada, Kazuyo Okamoto, Yasuyuki Okamoto   +5 more
doaj   +1 more source

Perioperative endocrine dynamics in euthyroid versus hyperthyroid patients with Graves’ disease undergoing total thyroidectomy: a prospective cohort study

BMC Surgery
Background Total thyroidectomy is a definitive treatment for Graves’ disease, but perioperative endocrine dynamics may differ depending on preoperative thyroid function.
Hiroyuki Yamashita, Kouichi Yoshimoto, Misa Okamura, Hisakazu Shindo, Yusuke Mori, Kento Katsuyama, Daisuke Tatsushima, Seigo Tachibana, Takashi Fukuda, Atushi Yamaoka, Hiroshi Takahashi, Yuji Nagayama, Shinya Sato   +12 more
doaj   +1 more source